Cuvitru Market Report 2026

Cuvitru Market Overview

• The Cuvitru market growth in the historic period has been driven by growing diagnosis of primary immunodeficiency disorders, expansion of plasma collection networks • Market expansion is supported by expansion of home healthcare immunotherapy, rising demand for convenient self-administration options • Growth Driver: Rising Prevalence Of Immunodeficiency Diseases Driving The Market Growth • Asia-Pacific was the largest region in 2025.

What Is Covered Under Cuvitru Market?

Cuvitru is a medication containing immunoglobulin, specifically human immune globulin, used to treat primary immunodeficiencies. It supports patients with compromised immune systems by delivering necessary antibodies that their bodies cannot produce. It replenishes antibodies in individuals with conditions such as chronic granulomatous disease or severe combined immunodeficiency. The main indications of cuvitru are common variable immunodeficiency (CVID), x-linked agammaglobulinemia, and severe combined immunodeficiency (SCID). Common Variable Immunodeficiency (CVID) is a primary immunodeficiency causing reduced antibody production and frequent infections; Cuvitru treats it by restoring antibody levels through immunoglobulin replacement therapy. It is distributed through various channels such as hospitals pharmacies, specialty pharmacies, and home healthcare providers. It has end use in clinics, homecare, hospitals, and other end uses.

What Is The Cuvitru Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of home healthcare immunotherapy, rising demand for convenient self-administration options, increasing investment in plasma fractionation capacity, growing focus on personalized dosing regimens, advancement in immunoglobulin formulation technologies. Major trends in the forecast period include increasing use of subcutaneous immunoglobulin therapies, rising preference for home-based infusion treatments, expansion of long-term immunodeficiency management, improved patient-centric delivery methods, enhanced plasma-derived product safety.

Global Cuvitru Market Segmentation

1) By Indication: Common Variable Immunodeficiency (CVID), X-Linked Agammaglobulinemia, Severe Combined Immunodeficiency (SCID) 2) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Home Healthcare Providers 3) By End-Use: Clinics, Homecare, Hospitals, Other End-Uses

What Are The Drivers Of The Cuvitru Market?

The increase in the prevalence of immunodeficiency diseases is expected to propel the growth of the cuvitru market going forward. Immunodeficiency diseases are a group of disorders where the immune system cannot function properly, making individuals more susceptible to infections and certain other health complications. The increase in immunodeficiency diseases can be attributed to several factors, including better diagnostic techniques leading to higher detection rates, environmental factors such as pollution and climate change affecting immune function, and an aging population more prone to immune system decline. Cuvitru is a crucial treatment option for individuals with immunodeficiency diseases, as it provides subcutaneous immunoglobulin replacement therapy, helping to restore the immune system and reduce the frequency and severity of infections in patients with primary and secondary immunodeficiencies. For instance, in 2023, according to the Immune Deficiency Foundation (IDF), a US-based non-profit organization, around 1,177 patients were living with primary immunodeficiency (PI), with common variable immune deficiency (CVID) being the most prevalent diagnosis at 62%. Therefore, the increase in the prevalence of immune deficiency diseases will drive the growth in the cuvitru industry. The increase in healthcare spending is expected to propel the growth of the cuvitru market going forward. Healthcare spending refers to the financial resources governments, organizations, and individuals allocate to provide healthcare services, including hospital care, medical treatments, pharmaceuticals, and preventive services. The increasing healthcare spending is driven by factors such as the rising prevalence of chronic diseases, aging populations, technological advancements in medical treatments, and the need for improved access to healthcare services, all of which demand more resources to maintain and improve public health outcomes. The increase in healthcare spending is fueling the growth of the cuvitru by enabling greater access to advanced immunoglobulin therapies for individuals with immune deficiencies. For instance, in November 2024, according to a report published by the Health Foundation, a UK-based independent charity committed to focus on health care, National Health Service (NHS) England’s funding is set to rise from £171 billion ($216.10 billion) in the 2023/24 fiscal year to £192 billion ($242.64 billion) by 2025/26. Therefore, the increase in healthcare spending will drive the growth of the cuvitru industry. The increase in the aging population is expected to propel the growth of the cuvitru market going forward. The aging population refers to individuals aged 65 and older who experience various age-related changes, such as reduced skin elasticity, wrinkles, and fine lines. The increase in the geriatric population is due to improved healthcare, better living standards, and advances in medical treatments that have led to longer life expectancies. Cuvitru is used in the aging population to treat primary immunodeficiency by providing immunoglobulin replacement therapy to boost weakened immune systems. For instance, in January 2024, according to a report published by the Population Reference Bureau, a US-based non-profit organization responsible for collecting stats for research and academic purposes, the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. As a result, this age group’s proportion of the total U.S. population will grow from 17% to 23% during this period. Therefore, the increase in the aging population will propel the growth of the cuvitru industry.

Key Players In The Global Cuvitru Market

Major companies operating in the cuvitru market are Takeda Pharmaceutical Company Limited (Baxalta US Inc.)

Regional Insights

Asia-Pacific was the largest region in the cuvitru market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Cuvitru Market?

The cuvitru market consists of sales of human immune globulin solution, infusion pumps, needles and syringes, and IV sets and tubing. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cuvitru Market Report 2026?

The cuvitru market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cuvitru industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.